Other Species / Isoforms
  EEF2K (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S18-p
EGVDGGQsPRAGHDG
Upstream
1 35
Treatment
  • EGF
  • nocodazole
EEF2K (human) EGVDGGQsPRAGHDG S18-p
EEF2K (mouse) EGVDGGRCsRAGHNA C18
EEF2K (rat) EGVDGGGsSGAGRHG S18-p
P19
GVDGGQsPRAGHDGD
0 1
EEF2K (human) GVDGGQsPRAGHDGD P19
EEF2K (mouse) GVDGGRCsRAGHNAD S19-p
EEF2K (rat) GVDGGGsSGAGRHGD S19
S27-p
RAGHDGDsDGDsDDE
0 16
EEF2K (human) RAGHDGDsDGDsDDE S27-p
EEF2K (mouse) RAGHNADsDtDsDDD S27-p
EEF2K (rat) GAGRHGDSDTDSDDD S27
G29
GHDGDsDGDsDDEEG
0 5
EEF2K (human) GHDGDsDGDsDDEEG G29
EEF2K (mouse) GHNADsDtDsDDDEG T29-p
EEF2K (rat) GRHGDSDTDSDDDEG T29
S31-p
DGDsDGDsDDEEGyF
0 14
EEF2K (human) DGDsDGDsDDEEGyF S31-p
EEF2K (mouse) NADsDtDsDDDEGYF S31-p
EEF2K (rat) HGDSDTDSDDDEGYF S31
Y37-p
DsDDEEGyFICPITD
0 3
EEF2K (human) DsDDEEGyFICPITD Y37-p
EEF2K (mouse) DsDDDEGYFICPITD Y37
EEF2K (rat) DSDDDEGYFICPITD Y37
K58-ub
NVNSKVNkyysNLTk
0 2
EEF2K (human) NVNSKVNkyysNLTk K58-ub
EEF2K (mouse) NVSSKVQSYYSNLTK S58
EEF2K (rat) NVNSKGQGYYNNLLK G58
Y59-p
VNSKVNkyysNLTks
0 11
EEF2K (human) VNSKVNkyysNLTks Y59-p
EEF2K (mouse) VSSKVQSYYSNLTKT Y59
EEF2K (rat) VNSKGQGYYNNLLKT Y59
Y60-p
NSKVNkyysNLTksE
0 35
EEF2K (human) NSKVNkyysNLTksE Y60-p
EEF2K (mouse) SSKVQSYYSNLTKTE Y60
EEF2K (rat) NSKGQGYYNNLLKTE Y60
S61-p
SKVNkyysNLTksER
1 6
EEF2K (human) SKVNkyysNLTksER S61-p
EEF2K (mouse) SKVQSYYSNLTKTEC S61
EEF2K (rat) SKGQGYYNNLLKTEC N61
K65-ub
kyysNLTksERysss
Upstream
0 3
Treatment
  • MG132
EEF2K (human) kyysNLTksERysss K65-ub
EEF2K (mouse) SYYSNLTKTECGstG K65
EEF2K (rat) GYYNNLLKTECGSTG K65
S66-p
yysNLTksERysssG
1 1
EEF2K (human) yysNLTksERysssG S66-p
EEF2K (mouse) YYSNLTKTECGstGs T66
EEF2K (rat) YYNNLLKTECGSTGs T66
Y69-p
NLTksERysssGsPA
Upstream
Downstream
0 1
Effects on Modified Protein
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • translation, induced
Treatment
  • pictilisib
EEF2K (human) NLTksERysssGsPA Y69-p
EEF2K (mouse) SNLTKTECGstGsPA C68
EEF2K (rat) NNLLKTECGSTGsPA C68
S70-p
LTksERysssGsPAN
Upstream
Downstream
1 4
Effects on Modified Protein
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • translation, induced
Treatment
  • AZD8055
  • insulin
  • PF-4708671
  • pictilisib
  • rapamycin
  • selumetinib
view more >
EEF2K (human) LTksERysssGsPAN S70-p
EEF2K (mouse) NLTKTECGstGsPAs G69
EEF2K (rat) NLLKTECGSTGsPAS G69
S71-p
TksERysssGsPANs
0 7
EEF2K (human) TksERysssGsPANs S71-p
EEF2K (mouse) LTKTECGstGsPAss S70-p
EEF2K (rat) LLKTECGSTGsPASS S70
S72-p
ksERysssGsPANsF
Upstream
Downstream
0 13
Effects on Modified Protein
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • translation, induced
Putative in vivo kinases:
  • mTOR (human)
Treatment
  • lapatinib
  • pictilisib
  • rapamycin
  • Torin1
  • Trametinib
view more >
EEF2K (human) ksERysssGsPANsF S72-p
EEF2K (mouse) TKTECGstGsPAssF T71-p
EEF2K (rat) LKTECGSTGsPASSF T71
S74-p
ERysssGsPANsFHF
Upstream
Downstream
1 31
Effects on Modified Protein
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • translation, induced
Putative in vivo kinases:
  • mTOR (human)
Treatment
  • ischemia
  • pictilisib
  • rapamycin
  • Torin1
view more >
EEF2K (human) ERysssGsPANsFHF S74-p
EEF2K (mouse) TECGstGsPAssFHF S73-p
EEF2K (rat) TECGSTGsPASSFHF S73-p
N77
sssGsPANsFHFkEA
0 3
EEF2K (human) sssGsPANsFHFkEA N77
EEF2K (mouse) GstGsPAssFHFKEA S76-p
EEF2K (rat) GSTGsPASSFHFKEA S76
S78-p
ssGsPANsFHFkEAW
Upstream
Downstream
7 14
Effects on Modified Protein
  • enzymatic activity, induced
  • enzymatic activity, inhibited
  • molecular association, regulation
Effects on Biological Processes:
  • autophagy, inhibited
  • cell growth, induced
Kinase, in vitro:
  • ChaK1 (human)
  • EEF2K (human)
Treatment
  • 2-deoxyglucose
  • amino_acid_starvation
  • AZD8055
  • glucose_starvation
  • insulin
  • pictilisib
  • rapamycin
  • Ro31-8220
  • serum_starvation
  • thapsigargin
  • Trametinib
  • U0126
  • wortmannin
view more >
EEF2K (human) ssGsPANsFHFkEAW S78-p
EEF2K (mouse) stGsPAssFHFKEAW S77-p
EEF2K (rat) STGsPASSFHFKEAW S77
K82-ub
PANsFHFkEAWkHAI
0 1
EEF2K (human) PANsFHFkEAWkHAI K82-ub
EEF2K (mouse) PAssFHFKEAWKHAI K81
EEF2K (rat) PASSFHFKEAWKHAI K81
K86-ub
FHFkEAWkHAIQKAk
0 1
EEF2K (human) FHFkEAWkHAIQKAk K86-ub
EEF2K (mouse) FHFKEAWKHAIEKAK K85
EEF2K (rat) FHFKEAWKHAIEKAK K85
K93-ub
kHAIQKAkHMPDPWA
0 1
EEF2K (human) kHAIQKAkHMPDPWA K93-ub
EEF2K (mouse) KHAIEKAKHMPDPWA K92
EEF2K (rat) KHAIEKAKHMPDPWA K92
K132-ub
LDDEVLIkMAsQPFG
0 1
EEF2K (human) LDDEVLIkMAsQPFG K132-ub
EEF2K (mouse) LKDEVLIKMASQPFG K131
EEF2K (rat) LKDEVLIKMASQPFG K131
S135-p
EVLIkMAsQPFGRGA
0 1
EEF2K (human) EVLIkMAsQPFGRGA S135-p
EEF2K (mouse) EVLIKMASQPFGRGA S134
EEF2K (rat) EVLIKMASQPFGRGA S134
K151-ub
RECFRTKkLSNFLHA
0 1
EEF2K (human) RECFRTKkLSNFLHA K151-ub
EEF2K (mouse) RECFRTKKLSNFLHA K150
EEF2K (rat) RECFRTKKLSNFLHA K150
K162-ub
FLHAQQWkGASNYVA
Upstream
0 2
Treatment
  • MG132
EEF2K (human) FLHAQQWkGASNYVA K162-ub
EEF2K (mouse) FLHAQQWKGASNYVA K161
EEF2K (rat) FLHAQHWKGASNYVA K161
K170-ub
GASNYVAkRYIEPVD
0 1
EEF2K (human) GASNYVAkRYIEPVD K170-ub
EEF2K (mouse) GASNYVAKRYIEPVD K169
EEF2K (rat) GASNYVAKRYLEPVD K169
R178-m1
RYIEPVDrDVYFEDV
0 1
EEF2K (human) RYIEPVDrDVYFEDV R178-m1
EEF2K (mouse) RYIEPVDRSVYFEDV R177
EEF2K (rat) RYLEPVDRSVYFEDV R177
K202-ub
GEEYNRHkPPKQVDI
0 1
EEF2K (human) GEEYNRHkPPKQVDI K202-ub
EEF2K (mouse) GEDYNRHKPPKQVDI K201
EEF2K (rat) GEEYNRHKPPKQVDI K201
K223-ub
ELKDRPGkPLFHLEH
0 1
EEF2K (human) ELKDRPGkPLFHLEH K223-ub
EEF2K (mouse) ELKDRPGQPLFHLEH Q222
EEF2K (rat) ELKDRQGQPLFHLEH Q222
K235-ub
LEHYIEGkYIkYNsN
0 1
EEF2K (human) LEHYIEGkYIkYNsN K235-ub
EEF2K (mouse) LEHYIEGKYIKYNSN K234
EEF2K (rat) LEHYIEGKYIKYNSN K234
K238-ub
YIEGkYIkYNsNsGF
0 2
EEF2K (human) YIEGkYIkYNsNsGF K238-ub
EEF2K (mouse) YIEGKYIKYNSNSGF K237
EEF2K (rat) YIEGKYIKYNSNSGF K237
S241-p
GkYIkYNsNsGFVRD
0 1
EEF2K (human) GkYIkYNsNsGFVRD S241-p
EEF2K (mouse) GKYIKYNSNSGFVRD S240
EEF2K (rat) GKYIKYNSNSGFVRD S240
S243-p
YIkYNsNsGFVRDDN
0 2
EEF2K (human) YIkYNsNsGFVRDDN S243-p
EEF2K (mouse) YIKYNSNSGFVRDDN S242
EEF2K (rat) YIKYNSNSGFVRDDN S242
T254
RDDNIRLTPQAFSHF
1 0
EEF2K (human) RDDNIRLTPQAFSHF T254
EEF2K (mouse) RDDNIRLTPQAFSHF T253
EEF2K (rat) RDDNIRLtPQAFSHF T253-p
T340-p
RDAVNQNtkLLQsAk
0 1
EEF2K (human) RDAVNQNtkLLQsAk T340-p
EEF2K (mouse) QDAVNQSTRLLQSAK T339
EEF2K (rat) QDAVNQSTKLLQSAK T339
K341-ub
DAVNQNtkLLQsAkt
Upstream
1 24
Treatment
  • MG132
EEF2K (human) DAVNQNtkLLQsAkt K341-ub
EEF2K (mouse) DAVNQSTRLLQSAKt R340
EEF2K (rat) DAVNQSTKLLQSAKt K340
S345-p
QNtkLLQsAktILRG
0 1
EEF2K (human) QNtkLLQsAktILRG S345-p
EEF2K (mouse) QSTRLLQSAKtILRG S344
EEF2K (rat) QSTKLLQSAKtILRG S344
K347-ub
tkLLQsAktILRGtE
Upstream
1 18
Treatment
  • MG132
EEF2K (human) tkLLQsAktILRGtE K347-ub
EEF2K (mouse) TRLLQSAKtILRGtE K346
EEF2K (rat) TKLLQSAKtILRGTE K346
T348-p
kLLQsAktILRGtEE
Upstream
Downstream
9 26
Effects on Modified Protein
  • enzymatic activity, induced
  • phosphorylation
  • protein conformation
  • protein degradation
Kinase, in vitro:
  • EEF2K (human)
Putative in vivo kinases:
  • EEF2K (human)
Regulatory protein:
  • EEF2K (human)
Treatment
  • 2-deoxyglucose
  • A484954
  • bradykinin
  • calyculin_A
  • cpTOME
  • H2O2
  • ionomycin
  • low_glucose
  • NKH_477
  • serum_starvation
  • thapsigargin
view more >
EEF2K (human) kLLQsAktILRGtEE T348-p
EEF2K (mouse) RLLQSAKtILRGtEE T347-p
EEF2K (rat) KLLQSAKtILRGTEE T347-p
T353-p
AktILRGtEEKCGsP
Upstream
1 6
Kinase, in vitro:
  • EEF2K (human)
EEF2K (human) AktILRGtEEKCGsP T353-p
EEF2K (mouse) AKtILRGtEEKCGsP T352-p
EEF2K (rat) AKtILRGTEEKCGsP T352
S359-p
GtEEKCGsPQVRtLs
Upstream
Downstream
6 9
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • CDK1 (human)
  • P38D (human)
Putative in vivo kinases:
  • CDK1 (human)
  • P38D (human)
Treatment
  • 2-deoxyglucose
  • amino_acid_starvation
  • anisomycin
  • IGF-1
  • insulin
  • rapamycin
  • Ro31-8220
  • SB203580
  • seliciclib
  • TNF
  • U0126
  • wortmannin
view more >
EEF2K (human) GtEEKCGsPQVRtLs S359-p
EEF2K (mouse) GtEEKCGsPRIRtLs S358-p
EEF2K (rat) GTEEKCGsPRIRTLs S358-p
T364-p
CGsPQVRtLsGSRPP
0 3
EEF2K (human) CGsPQVRtLsGSRPP T364-p
EEF2K (mouse) CGsPRIRtLsSsRPP T363-p
EEF2K (rat) CGsPRIRTLsGSRPP T363
S366-p
sPQVRtLsGSRPPLL
Upstream
Downstream
16 31
EEF2K (human)
S366-p
Effects on Modified Protein
  • enzymatic activity, induced
  • enzymatic activity, inhibited
  • phosphorylation
Effects on Biological Processes:
  • autophagy, inhibited
  • translation, induced
Kinase, in vitro:
  • EEF2K (human)
  • p70S6K (human)
  • P70S6KB (human)
  • p90RSK (human)
view more >
Putative in vivo kinases:
  • p70S6K (human)
  • p90RSK (human)
Regulatory protein:
  • EEF2K (human)
  • Epac1 (human)
Treatment
  • (R)-CE3F4
  • 2-deoxyglucose
  • A484954
  • BRD7389
  • cpTOME
  • FCCP
  • ghrelin
  • glucose
  • glucose_starvation
  • HJC0197
  • IGF-1
  • insulin
  • low_glucose
  • LY294002
  • metoprolol
  • NKH_477
  • okadaic_acid
  • PD184352
  • PF-4708671
  • phorbol_ester
  • pictilisib
  • rapamycin
  • Ro31-8220
  • serum_starvation
  • thapsigargin
  • Trametinib
  • U0126
  • wortmannin
view more >
EEF2K (human) sPQVRtLsGSRPPLL S366-p
EEF2K (mouse) sPRIRtLsSsRPPLL S365-p
EEF2K (rat) sPRIRTLsGSRPPLL S365-p
S368
QVRtLsGSRPPLLRP
0 2
EEF2K (human) QVRtLsGSRPPLLRP S368
EEF2K (mouse) RIRtLsSsRPPLLLR S367-p
EEF2K (rat) RIRTLsGSRPPLLLR S367
S377-p
PPLLRPLsENsGDEN
Upstream
3 4
Putative in vivo kinases:
  • MAPKAPK2 (human)
Treatment
  • 2-deoxyglucose
  • anisomycin
  • insulin
  • SB203580
  • TNF
view more >
EEF2K (human) PPLLRPLsENsGDEN S377-p
EEF2K (mouse) PPLLLRLSENsGDEN S376
EEF2K (rat) PPLLLRLSENSGDEN S376
S380-p
LRPLsENsGDENMSD
0 5
EEF2K (human) LRPLsENsGDENMSD S380-p
EEF2K (mouse) LLRLSENsGDENMsD S379-p
EEF2K (rat) LLRLSENSGDENMSD S379
S386
NsGDENMSDVTFDsL
0 2
EEF2K (human) NsGDENMSDVTFDsL S386
EEF2K (mouse) NsGDENMsDVTFDsL S385-p
EEF2K (rat) NSGDENMSDVTFDsL S385
S392-p
MSDVTFDsLPssPss
2 17
EEF2K (human) MSDVTFDsLPssPss S392-p
EEF2K (mouse) MsDVTFDsLPssPss S391-p
EEF2K (rat) MSDVTFDsLPSsPSS S391-p
S395-p
VTFDsLPssPssAtP
0 4
EEF2K (human) VTFDsLPssPssAtP S395-p
EEF2K (mouse) VTFDsLPssPssATP S394-p
EEF2K (rat) VTFDsLPSsPSSATP S394
S396-p
TFDsLPssPssAtPH
Upstream
5 12
Kinase, in vitro:
  • P38B (human)
  • P38D (human)
Putative in vivo kinases:
  • EEF2K (human)
Treatment
  • 2-deoxyglucose
  • insulin
EEF2K (human) TFDsLPssPssAtPH S396-p
EEF2K (mouse) TFDsLPssPssATPH S395-p
EEF2K (rat) TFDsLPSsPSSATPH S395-p
S398-p
DsLPssPssAtPHSQ
Upstream
Downstream
3 4
Effects on Biological Processes:
  • apoptosis, inhibited
  • autophagy, induced
Kinase, in vitro:
  • AMPKA1 (human)
Putative in vivo kinases:
  • AMPKA1 (human)
  • AMPKA2 (human)
Treatment
  • 2-deoxyglucose
  • acadesine
  • adriamycin
  • CCCP
  • compound_C
  • SB203580
  • thapsigargin
view more >
EEF2K (human) DsLPssPssAtPHSQ S398-p
EEF2K (mouse) DsLPssPssATPHsQ S397-p
EEF2K (rat) DsLPSsPSSATPHSQ S397
S399-p
sLPssPssAtPHSQK
0 2
EEF2K (human) sLPssPssAtPHSQK S399-p
EEF2K (mouse) sLPssPssATPHsQK S398-p
EEF2K (rat) sLPSsPSSATPHSQK S398
T401-p
PssPssAtPHSQKLD
0 1
EEF2K (human) PssPssAtPHSQKLD T401-p
EEF2K (mouse) PssPssATPHsQKLD T400
EEF2K (rat) PSsPSSATPHSQKLD T400
S404
PssAtPHSQKLDHLH
0 1
EEF2K (human) PssAtPHSQKLDHLH S404
EEF2K (mouse) PssATPHsQKLDHLH S403-p
EEF2K (rat) PSSATPHSQKLDHLH S403
S416-p
HLHWPVFsDLDNMAS
0 1
EEF2K (human) HLHWPVFsDLDNMAS S416-p
EEF2K (mouse) HLHWPVFGDLDNMGP G415
EEF2K (rat) HLHWPVFGDLDNMGP G415
S435-p
HLDNHREsENsGDsG
0 3
EEF2K (human) HLDNHREsENsGDsG S435-p
EEF2K (mouse) RMDNHRDsENsGDSG S434-p
EEF2K (rat) RMDNHRDSENSGDSG S434
S438-p
NHREsENsGDsGyPs
0 3
EEF2K (human) NHREsENsGDsGyPs S438-p
EEF2K (mouse) NHRDsENsGDSGYPs S437-p
EEF2K (rat) NHRDSENSGDSGYPs S437
S441-p
EsENsGDsGyPsEkR
Upstream
Downstream
2 3
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • translation, induced
Kinase, in vitro:
  • EEF2K (human)
Treatment
  • NH125
EEF2K (human) EsENsGDsGyPsEkR S441-p
EEF2K (mouse) DsENsGDSGYPsEKR S440
EEF2K (rat) DSENSGDSGYPsEKR S440
Y443-p
ENsGDsGyPsEkRGE
0 2
EEF2K (human) ENsGDsGyPsEkRGE Y443-p
EEF2K (mouse) ENsGDSGYPsEKRsD Y442
EEF2K (rat) ENSGDSGYPsEKRSD Y442
S445-p
sGDsGyPsEkRGELD
Upstream
Downstream
4 36
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • translation, induced
  • translation, inhibited
Kinase, in vitro:
  • EEF2K (human)
Putative in vivo kinases:
  • EEF2K (human)
Treatment
  • 2-deoxyglucose
  • A484954
  • ischemia
  • NH125
  • pictilisib
  • Trametinib
view more >
EEF2K (human) sGDsGyPsEkRGELD S445-p
EEF2K (mouse) sGDSGYPsEKRsDLD S444-p
EEF2K (rat) SGDSGYPsEKRSDLD S444-p
K447-ub
DsGyPsEkRGELDDP
0 1
EEF2K (human) DsGyPsEkRGELDDP K447-ub
EEF2K (mouse) DSGYPsEKRsDLDDP K446
EEF2K (rat) DSGYPsEKRSDLDDP K446
G449
GyPsEkRGELDDPEP
0 2
EEF2K (human) GyPsEkRGELDDPEP G449
EEF2K (mouse) GYPsEKRsDLDDPEP S448-p
EEF2K (rat) GYPsEKRSDLDDPEP S448
S462-p
EPREHGHsYSNRkYE
0 1
EEF2K (human) EPREHGHsYSNRkYE S462-p
EEF2K (mouse) EPREHGHSNGNRRHE S461
EEF2K (rat) EPREHGHSNGNRRPE S461
K467-sm
GHsYSNRkYEsDEDs
0 1
EEF2K (human) GHsYSNRkYEsDEDs K467-sm
EEF2K (mouse) GHSNGNRRHEsDEDs R466
EEF2K (rat) GHSNGNRRPEsDEDs R466
S470-p
YSNRkYEsDEDsLGs
Upstream
0 48
Treatment
  • BI2536
  • dasatinib
  • EGF
  • ischemia
  • MLN8054
  • U0126
view more >
EEF2K (human) YSNRkYEsDEDsLGs S470-p
EEF2K (mouse) NGNRRHEsDEDsLGs S469-p
EEF2K (rat) NGNRRPEsDEDsLGs S469-p
S474-p
kYEsDEDsLGssGRV
Upstream
1 43
Kinase, in vitro:
  • EEF2K (human)
Treatment
  • EGF
  • ischemia
  • U0126
view more >
EEF2K (human) kYEsDEDsLGssGRV S474-p
EEF2K (mouse) RHEsDEDsLGsSGRV S473-p
EEF2K (rat) RPEsDEDsLGsSGRV S473-p
S477-p
sDEDsLGssGRVCVE
0 12
EEF2K (human) sDEDsLGssGRVCVE S477-p
EEF2K (mouse) sDEDsLGsSGRVCVE S476-p
EEF2K (rat) sDEDsLGsSGRVCVE S476-p
S478-p
DEDsLGssGRVCVEk
0 3
EEF2K (human) DEDsLGssGRVCVEk S478-p
EEF2K (mouse) DEDsLGsSGRVCVET S477
EEF2K (rat) DEDsLGsSGRVCVET S477
K485-ub
sGRVCVEkWNLLNss
1 25
EEF2K (human) sGRVCVEkWNLLNss K485-ub
EEF2K (mouse) SGRVCVETWNLLNPS T484
EEF2K (rat) SGRVCVETWNLLNPS T484
S491-p
EkWNLLNssRLHLPR
1 6
EEF2K (human) EkWNLLNssRLHLPR S491-p
EEF2K (mouse) ETWNLLNPSRLHLPR P490
EEF2K (rat) ETWNLLNPSRLHLPR P490
S492-p
kWNLLNssRLHLPRA
0 2
EEF2K (human) kWNLLNssRLHLPRA S492-p
EEF2K (mouse) TWNLLNPSRLHLPRP S491
EEF2K (rat) TWNLLNPSRLHLPRP S491
S500-p
RLHLPRAsAVALEVQ
Upstream
Downstream
5 11
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • protein conformation
Kinase, in vitro:
  • EEF2K (human)
Putative in vivo kinases:
  • EEF2K (human)
Treatment
  • calyculin_A
  • colforsin
  • ionomycin
view more >
EEF2K (human) RLHLPRAsAVALEVQ S500-p
EEF2K (mouse) RLHLPRPsAVALEVQ S499-p
EEF2K (rat) RLHLPRPsAVALEVQ S499-p
K516-ub
LNALDLEkkIGksIL
0 4
EEF2K (human) LNALDLEkkIGksIL K516-ub
EEF2K (mouse) LNALDLGRKIGKSVL R515
EEF2K (rat) LNALDLGRKIGKSVL R515
K517-ub
NALDLEkkIGksILG
0 1
EEF2K (human) NALDLEkkIGksILG K517-ub
EEF2K (mouse) NALDLGRKIGKSVLG K516
EEF2K (rat) NALDLGRKIGKSVLG K516
K520-ub
DLEkkIGksILGKVH
0 1
EEF2K (human) DLEkkIGksILGKVH K520-ub
EEF2K (mouse) DLGRKIGKSVLGKVH K519
EEF2K (rat) DLGRKIGKSVLGKVH K519
S521-p
LEkkIGksILGKVHL
0 1
EEF2K (human) LEkkIGksILGKVHL S521-p
EEF2K (mouse) LGRKIGKSVLGKVHL S520
EEF2K (rat) LGRKIGKSVLGKVHL S520
K596-ub
ETEENKTkGFDyLLk
0 1
EEF2K (human) ETEENKTkGFDyLLk K596-ub
EEF2K (mouse) ETEENKTKGFDYLLK K595
EEF2K (rat) ETEENKTKGFDYLLK K595
Y600-p
NKTkGFDyLLkAAEA
0 1
EEF2K (human) NKTkGFDyLLkAAEA Y600-p
EEF2K (mouse) NKTKGFDYLLKAAEA Y599
EEF2K (rat) NKTKGFDYLLKAAEA Y599
K603-ub
kGFDyLLkAAEAGDR
Downstream
1 19
Effects on Modified Protein
  • ubiquitination
EEF2K (human) kGFDyLLkAAEAGDR K603-ub
EEF2K (mouse) KGFDYLLKAAEAGDR K602
EEF2K (rat) KGFDYLLKAAEAGDR K602
S627-p
FDSGQNLsPDRCQDW
0 2
EEF2K (human) FDSGQNLsPDRCQDW S627-p
EEF2K (mouse) FDTGLNLsPDRCQDW S626-p
EEF2K (rat) FDTGLNLSPDRCQDW S626
K684-ub
TGGYGLEkDPQRSGD
1 2
EEF2K (human) TGGYGLEkDPQRSGD K684-ub
EEF2K (mouse) TGGFGLDKNPQRSGD K683
EEF2K (rat) TGGFGLDKNPQRSGD K683
K705-ub
EAAMEAMkGRLANQY
0 1
EEF2K (human) EAAMEAMkGRLANQY K705-ub
EEF2K (mouse) EAAMEAMKGRLANQY K704
EEF2K (rat) EAAMEAMKGRLANQY K704
K715-ub
LANQYYQkAEEAWAQ
0 1
EEF2K (human) LANQYYQkAEEAWAQ K715-ub
EEF2K (mouse) LANQYYEKAEEAWAQ K714
EEF2K (rat) LANQYYEKAEEAWAQ K714